• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用一维计算模型预测干粉吸入器的沉积。

Application of a One-Dimensional Computational Model for the Prediction of Deposition from a Dry Powder Inhaler.

机构信息

1 Department of Respiratory Medicine, Medical School, University of Thessaly , Larissa, Greece .

2 R&D, ELPEN Pharm. Co. Inc. , Athens, Greece .

出版信息

J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):435-443. doi: 10.1089/jamp.2016.1363. Epub 2017 Jul 6.

DOI:10.1089/jamp.2016.1363
PMID:28683222
Abstract

BACKGROUND

Accurate prediction of the regional deposition of inhaled dry powders as a function of powder properties and breathing pattern is a long-term research goal for pulmonary drug delivery. In the present work, deposition along the respiratory tract of dry powders of Fluticasone propionate and Salmeterol is predicted.

METHODS

A one-dimensional particle transport and deposition model is used, whose novelty is in the treatment of the alveolar space of each airway generation as an efficient mixing chamber. This assumption has been supported by simulations and measurements during the last 20 years. The model is applied to two popular pulmonary tree geometries, to investigate the effect of particle size on localized deposition and to estimate the uncertainty due to variations in airway size.

RESULTS AND CONCLUSIONS

Application of the model for the specific particle size distribution measured by a cascade impactor in the marketed product ELPENhaler, predicts the whole lung deposition (WLD), as well as the split between pulmonary (PU) and tracheobronchial (TB) deposition. Introduction in the model of modified particle size distributions with increased fractions of fine particles, indicates that the fine-particle dose is a satisfactory predictor of WLD but not of the PU/TB ratio.

摘要

背景

准确预测吸入干粉作为粉末特性和呼吸模式的函数的区域性沉积是肺部药物输送的长期研究目标。在目前的工作中,预测了丙酸氟替卡松和沙美特罗干粉在呼吸道中的沉积。

方法

使用一维颗粒输运和沉积模型,其新颖之处在于将每个气道代的肺泡空间视为有效的混合室。这一假设在过去 20 年的模拟和测量中得到了支持。该模型应用于两种流行的肺树几何形状,以研究粒径对局部沉积的影响,并估计由于气道尺寸变化引起的不确定性。

结果和结论

应用于市场产品 ELPENhaler 中级联撞击器测量的特定粒度分布的模型,预测了全肺沉积(WLD),以及肺部(PU)和气管支气管(TB)沉积之间的分割。在模型中引入具有增加的细颗粒分数的改性颗粒粒度分布表明,细颗粒剂量是 WLD 的一个满意的预测因子,但不是 PU/TB 比的预测因子。

相似文献

1
Application of a One-Dimensional Computational Model for the Prediction of Deposition from a Dry Powder Inhaler.应用一维计算模型预测干粉吸入器的沉积。
J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):435-443. doi: 10.1089/jamp.2016.1363. Epub 2017 Jul 6.
2
Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.丙酸氟替卡松和沙美特罗联合干粉吸入剂(胶囊型和多剂量型)在哮喘和 COPD 患者中的药代动力学和药效学。
J Aerosol Med Pulm Drug Deliv. 2014 Aug;27(4):279-89. doi: 10.1089/jamp.2013.1040. Epub 2013 Sep 28.
3
Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.干粉颗粒沉积密度对模拟肺部溶解和吸收速率的体外测试系统产生结果的影响。
Eur J Pharm Biopharm. 2019 Jun;139:213-223. doi: 10.1016/j.ejpb.2019.03.005. Epub 2019 Mar 9.
4
Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.采用胶囊型给药装置制备丙酸氟替卡松和沙美特罗辛酸钠的新型干粉吸入剂。
Pharm Dev Technol. 2018 Feb;23(2):158-166. doi: 10.1080/10837450.2017.1342656. Epub 2017 Jul 6.
5
Pharmacokinetics of Salmeterol and Fluticasone Propionate Delivered in Combination via Easyhaler and Diskus Dry Powder Inhalers in Healthy Subjects.舒利迭干粉吸入剂(沙美特罗替卡松)在健康受试者中的药代动力学。
J Aerosol Med Pulm Drug Deliv. 2018 Oct;31(5):290-297. doi: 10.1089/jamp.2017.1437. Epub 2018 Mar 1.
6
Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.人体全肺气道模型中颗粒传输与沉积的高效计算分析。第二部分:干粉吸入器应用。
Comput Biol Med. 2017 May 1;84:247-253. doi: 10.1016/j.compbiomed.2016.10.025. Epub 2016 Nov 3.
7
Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.目前的吸入器向下呼吸道支气管输送的剂量非常小:对健康肺和收缩肺的评估。
J Pharm Sci. 2016 Jan;105(1):147-59. doi: 10.1016/j.xphs.2015.11.027. Epub 2016 Jan 13.
8
Pharmacokinetic Models for Inhaled Fluticasone Propionate and Salmeterol Xinafoate to Quantify Batch-to-Batch Variability.吸入用丙酸氟替卡松和沙美特罗昔萘甲酸盐的药代动力学模型,用于量化批间变异性。
AAPS J. 2024 Apr 26;26(3):56. doi: 10.1208/s12248-024-00913-x.
9
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.流速对NEXThaler(®)与Diskus(®)和Turbohaler(®)干粉吸入器体外空气动力学性能的影响比较
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):167-78. doi: 10.1089/jamp.2015.1220. Epub 2015 Sep 10.
10
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.用于改善丙酸氟替卡松干粉吸入器性能的表面改性乳糖颗粒的制备与评价
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):254-67. doi: 10.1089/jamp.2014.1146. Epub 2014 Dec 17.